Novartis Advanced Accelerator Applications Receives FDA Approval for Lutathera Pharmaceutical Investing
Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical Trial Biotech Investing
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock Biotech Investing
Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
